Inventor profile of:

Andrew VAILLANT

City:

Roxboro

Country:

Canada

Published Applications:

21

Last publication date:

2023-02-23

Top Assignees for applications by Andrew VAILLANT

The entities that hold a legal rights for patent applications filed by inventor VAILLANT Andrew:

Recent patent applications by VAILLANT Andrew

Andrew VAILLANT from Roxboro, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-02-23
US20230056788A1
Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR THE INHIBITION OF HEPATITIS B AND HEPATITIS D VIRUS INFECTIONS

#2 | 2016-09-15
US20160263143A1
Human necessities

Methods for the treatment of hepatitis B and hepatitis D infections

#3 | 2016-01-14
US20160008393A1
Human necessities

Methods for the treatment of hepatitis B and hepatitis D virus infections

#4 | 2014-12-18
US20140369963A1
Chemistry; metallurgy

Methods for the treatment of hepatitis B and hepatitis D infections

#5 | 2014-12-18
US20140369962A1
Chemistry; metallurgy

Methods for the treatment of hepatitis B and hepatitis D infections

#6 | 2014-03-06
US20140065102A1
Human necessities

Methods for the treatment of hepatitis B and hepatitis D infections

#7 | 2013-11-21
US20130310445A1
Human necessities

Oligonucleotide chelate complex methods

#8 | 2013-11-21
US20130309201A1
Human necessities

Oligonucleotide chelate complex—polypeptide compositions and methods

#9 | 2013-11-07
US20130296410A1
Human necessities

Oligonucleotide chelate complexes

#10 | 2012-07-19
US20120184601A1
Chemistry; metallurgy

ANTIVIRAL OLIGONUCLEOTIDES

#11 | 2012-02-23
US20120046348A1
Human necessities

Oligonucleotide chelate complexes

#12 | 2010-07-08
US20100173980A1
Chemistry; metallurgy

ANTIVIRAL OLIGONUCLEOTIDES TARGETING RSV

#13 | 2009-08-27
US20090215873A1
Human necessities

Therapeutic Molecules and their Uses

#14 | 2009-06-18
US20090156527A1
Chemistry; metallurgy

Antiviral oligonucleotides targeting viral families

#15 | 2009-04-16
US20090099110A1
Chemistry; metallurgy

Antiviral oligonucleotides

#16 | 2009-02-12
US20090042827A1
Chemistry; metallurgy

Antiviral oligonucleotides targeting HBV

#17 | 2007-05-31
US20070123480A1
Chemistry; metallurgy

Oligonucleotides targeting prion diseases

#18 | 2006-06-22
US20060135458A1
Chemistry; metallurgy

Antiviral oligonucleotides

#19 | 2005-09-08
US20050196382A1
Human necessities

Antiviral oligonucleotides targeting viral families

#20 | 2005-08-11
US20050176661A1
Chemistry; metallurgy

Antiviral oligonucleotides

#21 | 2005-07-14
US20050153912A1
Chemistry; metallurgy

Antiviral oligonucleotides targeting viral families

InventorID:

520183 ⎘